Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilin Tang

Showing results (241-250 of 344) with videos related to

Pageof 35
Sort By:
Histopathology|October 12, 2021
EBV<sup>+</sup> high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional studyHui Liu, Zijun Y Xu-Monette, Guilin Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseZhihong Hu, Yi Sun, Ellen J Schlette, et al.
American Journal of Clinical Pathology|June 5, 2026
Clinicopathologic features of systemic ALK-negative anaplastic large cell lymphoma with TP53 deletionWei J Wang, Guilin Tang, L Jeffrey Medeiros, et al.
American Journal of Hematology|November 6, 2025
Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and OutcomesWei J Wang, Qiudan Shen, Mehrnoosh Tashakori, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2020
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myelomaSuyang Hao, Xinyan Lu, Zimu Gong, et al.
Annals of Diagnostic Pathology|April 30, 2022
Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and TP53 mutation: A report of two casesHong Fang, Gokce A Toruner, Zhenya Tang, et al.
Genes|January 8, 2025
Conventional Cytogenetic Analysis of Solid Tumor Abnormalities: A 25-Year Review of Proficiency Test Results from the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics CommitteeRachel K Vanderscheldon, William R Sukov, Juli-Anne Gardner, et al.
Leukemia & Lymphoma|November 10, 2017
Myeloid/lymphoid neoplasms with FGFR1 rearrangementPaolo Strati, Guilin Tang, Dzifa Y Duose, et al.
Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 10, 2015
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Pageof 35

Showing results (241-250 of 344) with videos related to

Sort By:
Pageof 35
Histopathology|October 12, 2021
EBV<sup>+</sup> high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional studyHui Liu, Zijun Y Xu-Monette, Guilin Tang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseZhihong Hu, Yi Sun, Ellen J Schlette, et al.
American Journal of Clinical Pathology|June 5, 2026
Clinicopathologic features of systemic ALK-negative anaplastic large cell lymphoma with TP53 deletionWei J Wang, Guilin Tang, L Jeffrey Medeiros, et al.
American Journal of Hematology|November 6, 2025
Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and OutcomesWei J Wang, Qiudan Shen, Mehrnoosh Tashakori, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2020
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myelomaSuyang Hao, Xinyan Lu, Zimu Gong, et al.
Annals of Diagnostic Pathology|April 30, 2022
Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and TP53 mutation: A report of two casesHong Fang, Gokce A Toruner, Zhenya Tang, et al.
Genes|January 8, 2025
Conventional Cytogenetic Analysis of Solid Tumor Abnormalities: A 25-Year Review of Proficiency Test Results from the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics CommitteeRachel K Vanderscheldon, William R Sukov, Juli-Anne Gardner, et al.
Leukemia & Lymphoma|November 10, 2017
Myeloid/lymphoid neoplasms with FGFR1 rearrangementPaolo Strati, Guilin Tang, Dzifa Y Duose, et al.
Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 10, 2015
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Pageof 35